Oppenheimer Cuts Dyne Therapeutics Price Target to $15 From $40
Oppenheimer also cut its rating on Dyne Therapeutics to Perform from Outperform.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.